company

Dine Brands

FAIRR Commentary

Dine Brands has made considerable progress over the last year with the release of a public policy on antibiotics addressing poultry and pork. This was published on 31 August 2018, and it goes beyond FDA compliance by stating that it will begin to prohibit the routine use of medically important antibiotics. Their policy stands out within the casual dining sector which has so far lagged behind the quick service restaurant sector.

FAIRR Recommendations

We are encouraged by Dine Brand’s commitment to antibiotics stewardship. However, we would encourage the company to:

  • Extend their policy to cover all relevant animal-derived proteins where antibiotics is prevalent.
  • Extend their policy to cover all relevant markets in which it operates in. Report more comprehensively and publicly on implementation progress including antibiotics use.
  • Extending the scope of their policy beyond medically important antibiotics in order to phase out the routine use of all antibiotics and/ or only use antibiotics when there is a disease present and administered by a veterinarian.
  • Report more comprehensively and publicly on implementation progress including antibiotics use.

Company Comment

Thank you for sharing your assessment with our team and we look forward to remaining in communication. We know research on animal welfare and the industry is constantly evolving and we are committed to continual improvements that makes sense for our guests, shareholders, business and planet.

See the company’s response to the engagement here.